论文部分内容阅读
前言 在英国(UK)和爱尔兰,输血被广泛用于医院的日常治疗,每年3百多万的血液成分发放于临床。在上世纪90年代初,英国的输血专家、血液学学者和其他临床医生,对输血中心的血液成分制备到临床输血整个过程的安全知识从知之甚少到逐渐提高,他们认为必须制定出重大的决策和临床指导方针,但是缺乏可靠的流行病学和统计学信息做基础。作为治疗性产品供应者,英国输血机构认为,了解他们的产品对病人构成的巨大危险
Foreword In the United Kingdom (UK) and Ireland, blood transfusions are widely used in the daily treatment of hospitals, and more than three million blood components are distributed clinically each year. In the early 1990s, British blood transfusion specialists, hematologists, and other clinicians knew little about how to improve the safety of blood transfusions from blood preparation to clinical blood transfusion. Decision-making and clinical guidelines, but lacking reliable epidemiological and statistical information as the basis. As a provider of therapeutic products, British blood transfusion agencies believe that understanding their products poses a great danger to patients